APO RESEARCH · REPORT
Peptide CXO
Peptide CXO covers outsourced research, process development and manufacturing for peptide programmes, from research material and analytical work to clinical and commercial supply.
Selected research
Industry Growth & Trends
Global Peptide CXO Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Peptide CXO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Peptide CXO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Peptide CXO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Peptide CXO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Peptide CXO market include Chinese Peptide Company, WuXi AppTec, Shenzhen JYMed Technology, ReaLi Tide Biological Technology, Jiangsu Sinopep-Allsino Biopharmaceutical, LONZA, Asymchem, GL Biochem and Chengdu Shengnuo Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Peptide CXO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Peptide CXO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peptide CXO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peptide CXO.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Peptide CXO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Peptide CXO Market by Company
Chinese Peptide Company
WuXi AppTec
Shenzhen JYMed Technology
ReaLi Tide Biological Technology
Jiangsu Sinopep-Allsino Biopharmaceutical
LONZA
Asymchem
GL Biochem
Chengdu Shengnuo Biotechnology
AmbioPharm
Polypeptide
Pepscan
JPT Peptide
Bicycle
Bachem
Peptide CXO Segment by Type
CRO
CMO/CDMO
Peptide CXO Segment by Application
Pharmaceutical Companies
Biotech Companies and Research Institutions
Peptide CXO Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide CXO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptide CXO and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide CXO.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Peptide CXO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- CRO
- CMO/CDMO
Applications
- Pharmaceutical Companies
- Biotech Companies and Research Institutions
Companies covered
- Chinese Peptide Company
- WuXi AppTec
- Shenzhen JYMed Technology
- ReaLi Tide Biological Technology
- Jiangsu Sinopep-Allsino Biopharmaceutical
- LONZA
- Asymchem
- GL Biochem
- Chengdu Shengnuo Biotechnology
- AmbioPharm
- Polypeptide
- Pepscan
- JPT Peptide
- Bicycle
- Bachem
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Peptide CXO Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Peptide CXO Market Size by Region (2021-2032)
- 1.4.1 Global Peptide CXO Market Size by Region (2021-2026)
- 1.4.2 Global Peptide CXO Market Size by Region (2027-2032)
- 1.5 Key Regions Peptide CXO Market Size (2021-2032)
- 1.5.1 North America Peptide CXO Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Peptide CXO Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Peptide CXO Market Size Growth Rate (2021-2032)
- 1.5.4 South America Peptide CXO Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Peptide CXO Market Size Growth Rate (2021-2032)
2 Peptide CXO Market by Type
- 2.1 Type Introduction
- 2.1.1 CRO
- 2.1.2 CMO/CDMO
- 2.2 Global Peptide CXO Market Size by Type
- 2.2.1 Global Peptide CXO Market Size Overview by Type (2021-2032)
- 2.2.2 Global Peptide CXO Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Peptide CXO Market Size Forecasted by Type (2027-2032)
- 2.3 Global Peptide CXO Market Size by Regions
- 2.3.1 North America Peptide CXO Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Peptide CXO Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Peptide CXO Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Peptide CXO Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Peptide CXO Market Size Breakdown by Type (2021-2026)
3 Peptide CXO Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Companies
- 3.1.2 Biotech Companies and Research Institutions
- 3.2 Global Peptide CXO Market Size by Application
- 3.2.1 Global Peptide CXO Market Size Overview by Application (2021-2032)
- 3.2.2 Global Peptide CXO Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Peptide CXO Market Size Forecasted by Application (2027-2032)
- 3.3 Global Peptide CXO Market Size by Regions
- 3.3.1 North America Peptide CXO Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Peptide CXO Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Peptide CXO Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Peptide CXO Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Peptide CXO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Peptide CXO Industry Trends
- 4.2 Peptide CXO Industry Drivers
- 4.3 Peptide CXO Industry Opportunities and Challenges
- 4.4 Peptide CXO Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Peptide CXO Revenue (2021-2026)
- 5.2 Global Peptide CXO Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Peptide CXO Key Company Headquarters & Area Served
- 5.4 Global Peptide CXO Company, Product Type & Application
- 5.5 Global Peptide CXO Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Peptide CXO Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Peptide CXO Players Market Share by Revenue in 2025
- 5.6.3 2025 Peptide CXO Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Chinese Peptide Company
- 6.1.1 Chinese Peptide Company Company Information
- 6.1.2 Chinese Peptide Company Business Overview
- 6.1.3 Chinese Peptide Company Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Chinese Peptide Company Peptide CXO Product Portfolio
- 6.1.5 Chinese Peptide Company Recent Developments
- 6.2 WuXi AppTec
- 6.2.1 WuXi AppTec Company Information
- 6.2.2 WuXi AppTec Business Overview
- 6.2.3 WuXi AppTec Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 WuXi AppTec Peptide CXO Product Portfolio
- 6.2.5 WuXi AppTec Recent Developments
- 6.3 Shenzhen JYMed Technology
- 6.3.1 Shenzhen JYMed Technology Company Information
- 6.3.2 Shenzhen JYMed Technology Business Overview
- 6.3.3 Shenzhen JYMed Technology Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Shenzhen JYMed Technology Peptide CXO Product Portfolio
- 6.3.5 Shenzhen JYMed Technology Recent Developments
- 6.4 ReaLi Tide Biological Technology
- 6.4.1 ReaLi Tide Biological Technology Company Information
- 6.4.2 ReaLi Tide Biological Technology Business Overview
- 6.4.3 ReaLi Tide Biological Technology Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 ReaLi Tide Biological Technology Peptide CXO Product Portfolio
- 6.4.5 ReaLi Tide Biological Technology Recent Developments
- 6.5 Jiangsu Sinopep-Allsino Biopharmaceutical
- 6.5.1 Jiangsu Sinopep-Allsino Biopharmaceutical Company Information
- 6.5.2 Jiangsu Sinopep-Allsino Biopharmaceutical Business Overview
- 6.5.3 Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CXO Product Portfolio
- 6.5.5 Jiangsu Sinopep-Allsino Biopharmaceutical Recent Developments
- 6.6 LONZA
- 6.6.1 LONZA Company Information
- 6.6.2 LONZA Business Overview
- 6.6.3 LONZA Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 LONZA Peptide CXO Product Portfolio
- 6.6.5 LONZA Recent Developments
- 6.7 Asymchem
- 6.7.1 Asymchem Company Information
- 6.7.2 Asymchem Business Overview
- 6.7.3 Asymchem Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Asymchem Peptide CXO Product Portfolio
- 6.7.5 Asymchem Recent Developments
- 6.8 GL Biochem
- 6.8.1 GL Biochem Company Information
- 6.8.2 GL Biochem Business Overview
- 6.8.3 GL Biochem Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 GL Biochem Peptide CXO Product Portfolio
- 6.8.5 GL Biochem Recent Developments
- 6.9 Chengdu Shengnuo Biotechnology
- 6.9.1 Chengdu Shengnuo Biotechnology Company Information
- 6.9.2 Chengdu Shengnuo Biotechnology Business Overview
- 6.9.3 Chengdu Shengnuo Biotechnology Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Chengdu Shengnuo Biotechnology Peptide CXO Product Portfolio
- 6.9.5 Chengdu Shengnuo Biotechnology Recent Developments
- 6.10 AmbioPharm
- 6.10.1 AmbioPharm Company Information
- 6.10.2 AmbioPharm Business Overview
- 6.10.3 AmbioPharm Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 AmbioPharm Peptide CXO Product Portfolio
- 6.10.5 AmbioPharm Recent Developments
- 6.11 Polypeptide
- 6.11.1 Polypeptide Company Information
- 6.11.2 Polypeptide Business Overview
- 6.11.3 Polypeptide Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Polypeptide Peptide CXO Product Portfolio
- 6.11.5 Polypeptide Recent Developments
- 6.12 Pepscan
- 6.12.1 Pepscan Company Information
- 6.12.2 Pepscan Business Overview
- 6.12.3 Pepscan Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Pepscan Peptide CXO Product Portfolio
- 6.12.5 Pepscan Recent Developments
- 6.13 JPT Peptide
- 6.13.1 JPT Peptide Company Information
- 6.13.2 JPT Peptide Business Overview
- 6.13.3 JPT Peptide Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 JPT Peptide Peptide CXO Product Portfolio
- 6.13.5 JPT Peptide Recent Developments
- 6.14 Bicycle
- 6.14.1 Bicycle Company Information
- 6.14.2 Bicycle Business Overview
- 6.14.3 Bicycle Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Bicycle Peptide CXO Product Portfolio
- 6.14.5 Bicycle Recent Developments
- 6.15 Bachem
- 6.15.1 Bachem Company Information
- 6.15.2 Bachem Business Overview
- 6.15.3 Bachem Peptide CXO Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Bachem Peptide CXO Product Portfolio
- 6.15.5 Bachem Recent Developments
7 North America
- 7.1 North America Peptide CXO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Peptide CXO Market Size by Country (2021-2026)
- 7.3 North America Peptide CXO Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Peptide CXO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Peptide CXO Market Size by Country (2021-2026)
- 8.3 Europe Peptide CXO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Peptide CXO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Peptide CXO Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Peptide CXO Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Peptide CXO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Peptide CXO Market Size by Country (2021-2026)
- 10.3 South America Peptide CXO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Peptide CXO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Peptide CXO Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Peptide CXO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst